ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Outcome"

  • 2022 American Transplant Congress

    25 Years of a Standardized Living Donor (LD) Intestinal Transplant Technique – What Has Been Achieved?

    R. Gruessner1, A. C. Gruessner2

    1SUNY Downstate Medical Center, Brooklyn, NY, 2SUNY Downstate Medical Center, Brooklyn, MA

    *Purpose: The indication for intestinal transplantation (ITX) is irreversible intestinal failure with dependence on total parenteral nutrition (TPN). Most intestinal transplants are from deceased donors…
  • 2022 American Transplant Congress

    Increased Costs, Cold Ischemia Time, and Sharing Associated with Removing DSA and OPTN Region from Kidney Allocation: A Single-Center Analysis

    R. Forbes1, A. Dreher1, E. Zavala2, L. A. Hickman1, L. Smith3, J. Lawson1, D. Shaffer1, B. P. Concepcion1

    1Vanderbilt University Medical Center, Nashville, TN, 2Transplant Center, Vanderbilt University Medical Center, Nashville, TN, 3Vanderbilt Transplant Center, Nashville, TN

    *Purpose: On March 15, 2021, Donation Service Area (DSA) and OPTN Region were removed from kidney allocation and replaced with a 250 nautical mile (NM)…
  • 2022 American Transplant Congress

    Living Donor Robotic Hysterectomy Provides Excellent Outcomes in Uterus Transplant Recipients

    L. Johannesson1, G. J. McKenna1, A. Wall2, J. Bayer1, G. Testa1

    1Baylor University Medical Center, Dallas, TX, 2Baylor Scott and White Dallas, Dallas, TX

    *Purpose: Living donor (LD) hysterectomy for Uterus Transplantation (UTx) can be performed robotically with vaginal extraction of the graft. There are no reports of the…
  • 2022 American Transplant Congress

    The Financial Burden Of Transplant – A Commercial Claims Analysis

    G. Katz-Greenberg1, O. Osazuwa-Peters1, J. Gonzalez1, S. Sanoff1, O. Oloruntoba1, N. Chan1, E. J. Gordon2, C. Scales1, A. Brookhart1, L. McElroy1

    1Duke University, Durham, NC, 2Surgery, Northwestern University Feinberg School of Medicine, OAK PARK, IL

    *Purpose: Despite access to health insurance, financial concerns are among the most prevalent patient-reported barriers to kidney and liver transplantation (KT and LT, respectively). We…
  • 2022 American Transplant Congress

    Efficacy and Safety of Delayed, Low-Dose Valganciclovir in High-Risk Cytomegalovirus Liver Transplant Recipients

    S. Anders1, A. Freeman1, L. Hutchinson1, U. Kaszubski1, M. Janusek1, A. Hooter2, D. Raymond2, C. Nguyen2

    1Ochsner Medical Center, New Orleans, LA, 2Xavier University, New Orleans, LA

    *Purpose: The goal of this study was to compare the safety and efficacy of a delayed valganciclovir (VGCV) dosing protocol for cytomegalovirus (CMV) prophylaxis in…
  • 2022 American Transplant Congress

    Single Cell Transcriptomics Reveal Allograft Immune Cell Patterns Associated with Histological Features of Acute Cellular Rejection in Liver Transplantation

    L. Tran1, A. Zahorchak1, C. Macedo1, T. Tabib2, F. Lakkis3, A. Humar1, D. Metes1, A. Thomson1

    1Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh Medical Center, Pittsburgh, PA, 3University of Pittsburgh Medical Center - Thomas E. Starzl Transplantation Institute, Pittsburgh, PA

    *Purpose: Development of successful tolerance induction strategies using immune cell-based therapies in transplantation depends on improved understanding of the local intra-graft cellular milieu that underlies…
  • 2022 American Transplant Congress

    Long-Term Clinical Outcomes in ABO Incompatible Kidney Transplantation in Patients with High Baseline Anti-A/B Antibody Titer

    S. Eum1, H. Lee1, E. Ko1, H. Yoon2, S. Shin2, C. Yang1, B. Chung1

    1Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, Seoul, Korea, Republic of, 2Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Hospital, Incheon, Korea, Republic of

    *Purpose: ABO incompatible (ABOi) kidney transplantation (KT) has been considered to overcome donor shortage. We investigated the long-term clinical outcomes in ABOi KT in patients…
  • 2022 American Transplant Congress

    Left Ventricular Diastolic Dysfunction: Prevalence and Relation to Outcomes in Liver Transplantation Recipients

    M. B. Hammami1, H. Allaham2, J. Grossman2, P. Xue2, K. Eagan2, S. Gottlieb2, C. Hong2, L. Wang2, C. Bhati2, D. Maluf2, K. Shetty2, N. Urrunaga2

    1University of Maryland, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD

    *Purpose: Assess the prevalence and characteristics of patients with pre-transplant left ventricular diastolic dysfunction (LVDD) and its potential impact on post-transplant morbidity and mortality.*Methods: Retrospective…
  • 2022 American Transplant Congress

    Six-Month Outcomes Among Lung Transplant Patients with COVID-19

    L. D. Mahan, J. Rose, M. Mohanka, A. Banga

    UT Southwestern Medical Center, Dallas, TX

    *Purpose: There is limited data on the outcomes beyond the acute illness among lung transplant (LT) patients with Coronavirus disease 2019 (COVID-19). The current study…
  • 2022 American Transplant Congress

    Liver Transplantation Outcomes for Budd-Chiari Syndrome in the MELD Era

    S. A. Alqahtani1, C. Schneider2, O. Sims3, A. Gurakar4, H. Tamim5, A. Bonder6, B. Saberi6

    1King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia, 2The Institute for Translational Medicine and Therapeutics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 3School of Medicine, School of Public Health, School of Arts and Sciences, University of Alabama at Birmingham, Birmingham, AL, 4Division of Gastroenterology & Hepatology, Johns Hopkins University, Baltimore, MD, 5Department of Internal Medicine, American University of Beirut, Beirut, Lebanon, 6Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    *Purpose: Budd Chiari syndrome (BCS) has a heterogeneous clinical presentations ranging from asymptomatic cases to fulminant liver failure with significant morbidly and mortality. Recent data…
  • 1
  • 2
  • 3
  • …
  • 155
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences